Osimertinib, Targeted therapy, EGFR mutation, Non-small cell lung cancer, Third-generation EGFR-TKI, Inhibits EGFR Ex19Del and L858R mutations, CNS metastasis activity,
Sale!
Lucius
Replica: Osimertinib EGFRm NSCLC Targeted Therapy
Original price was: $648.00.$489.00Current price is: $489.00.
Osimertinib, Targeted therapy, EGFR mutation, Non-small cell lung cancer, Third-generation EGFR-TKI, Inhibits EGFR Ex19Del and L858R mutations, CNS metastasis activity,